Point32health INC.

Health Plan

Based in MA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $3.8M in lobbying spend across 28 quarterly filings, Point32health INC is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2021 to 2025.

$3.8M
Total Spend
5
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2021$903K
2022$1.2M
2023$672K
2024$620K
2025$442K

Issues Lobbied

Health Issues

Lobbying Firms

Point32health INC.

Lobbyists

Christina Nyquist

Government Agencies Targeted

These are the government entities that Point32health INC. disclosed contacting in their lobbying filings.

Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESSENATEAgriculture, Dept of (USDA)Internal Revenue Service (IRS)Labor, Dept of (DOL)Treasury, Dept of
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

Issues related to health care policy

ACA/subsidies, COVID, telehealth, Medicare Advantage/Part D, Health Equity, Transparency

Health Care, Medicare, Medicaid, ACA, Commercial

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Pharma Lobbying
Industry overview and top spenders

Related Investigations

Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Akebia Therapeutics, INC.
$9.8M total spend
Ardelyx, INC.
$9.4M total spend
Sumitomo Pharma America, INC. (Formerly Sunovion Pharmaceuticals INC.)
$7.5M total spend
Sage Therapeutics
$4.8M total spend
Organogenesis INC.
$4.0M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.